Internal Medicine · Tampa, FL
NPI
1407044480
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
7756 Palm River Rd
Tampa, FL, 33619
Phone (813) 626-0066
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$540K
9,960 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Vianka Legra Delgado prescribed most often to Medicare patients was Atorvastatin Calcium, with 492 prescriptions and refills. In total Vianka Legra Delgado wrote 9,960 Medicare prescriptions that cost $540K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-20.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 492 | 1,389 | 154 | $3,568 |
| Lisinopril Generic | 360 | 1,037 | 110 | $2,200 |
| Amlodipine Besylate Generic | 323 | 888 | 100 | $981 |
| Gabapentin Generic | 323 | 670 | 99 | $3,340 |
| Losartan Potassium Generic | 305 | 828 | 89 | $2,243 |
| Metformin Hcl Generic | 287 | 848 | 96 | $1,251 |
| Omeprazole Generic | 246 | 651 | 74 | $1,821 |
| Levothyroxine Sodium Generic | 236 | 638 | 66 | $2,070 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 233 | 348 | 67 | $8,986 |
| Pantoprazole Sodium Generic | 226 | 552 | 69 | $1,442 |
| Furosemide Generic | 216 | 503 | 65 | $811 |
| Rosuvastatin Calcium Generic | 213 | 607 | 67 | $1,311 |
| Alprazolam Generic | 189 | 189 | 29 | $493 |
| Fluticasone Propionate Generic | 174 | 331 | 60 | $1,646 |
| Carvedilol Generic | 150 | 367 | 40 | $867 |
Brand drugs: 1,102 claims; generic drugs: 8,654 claims; opioid claims: 202.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Vianka Legra Delgado were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.